Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 338

1.

Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue.

Ferdinandi ES, Brazeau P, High K, Procter B, Fennell S, Dubreuil P.

Basic Clin Pharmacol Toxicol. 2007 Jan;100(1):49-58.

2.

Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.

Jansen M, Darby I, Abribat T, Dubreuil P, Ferdinandi ES, Hardy JG.

Int J Pharm. 2004 May 19;276(1-2):75-81.

PMID:
15113616
3.

A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation.

Falutz J, Allas S, Kotler D, Thompson M, Koutkia P, Albu J, Trottier B, Routy JP, Cote P, Abribat T, Grinspoon S.

AIDS. 2005 Aug 12;19(12):1279-87.

PMID:
16052083
4.

Pharmacodynamic evaluation of a PEGylated analogue of human growth hormone releasing factor in rats and pigs.

D'Antonio M, Louveau I, Esposito P, Bertolino M, Canali S.

Growth Horm IGF Res. 2004 Jun;14(3):226-34.

PMID:
15125884
5.

Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.

Rigamonti AE, Cella SG, Giordani C, Bonomo SM, Giunta M, Sartorio A, Muller E.

Neuroendocrinology. 2006;84(2):115-22. Epub 2006 Nov 9.

PMID:
17106185
6.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
7.

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.

Glaze ER, Lambert AL, Smith AC, Page JG, Johnson WD, McCormick DL, Brown AP, Levine BS, Covey JM, Egorin MJ, Eiseman JL, Holleran JL, Sausville EA, Tomaszewski JE.

Cancer Chemother Pharmacol. 2005 Dec;56(6):637-47. Epub 2005 Jun 29.

PMID:
15986212
8.

Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys.

Osborn BL, Sekut L, Corcoran M, Poortman C, Sturm B, Chen G, Mather D, Lin HL, Parry TJ.

Eur J Pharmacol. 2002 Dec 5;456(1-3):149-58.

PMID:
12450581
9.
10.

Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.

Campbell RM, Stricker P, Miller R, Bongers J, Liu W, Lambros T, Ahmad M, Felix AM, Heimer EP.

Peptides. 1994;15(3):489-95.

PMID:
7937325
11.
13.

Lead attenuation of episodic growth hormone secretion in male rats.

Berry WD Jr, Moriarty CM, Lau YS.

Int J Toxicol. 2002 Mar-Apr;21(2):93-8.

PMID:
12022635
14.

Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH).

Kovács M, Schally AV, Zarándi M, Groot K.

Peptides. 1997;18(3):431-8.

PMID:
9145432
15.

Effects of frequency of treatment with recombinant equine somatotropin on selected biological responses in geldings.

Thatcher CE, Thompson DL Jr.

Domest Anim Endocrinol. 2002 May;22(3):127-43.

PMID:
11934522
16.
17.

Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs.

Draghia-Akli R, Cummings KK, Khan AS, Brown PA, Carpenter RH.

J Anim Sci. 2003 Sep;81(9):2301-10.

18.

Investigation of human growth hormone releasing factor in adults.

Sassolas G, Biot-Laporte S, Cohen R, Chatelain P, Boissel JP, Dupin P, Garry P, Claustrat B, Girard P, Borson F.

Horm Res. 1986;24(2-3):99-111.

PMID:
3093356
19.

Gamma-hydroxybutyric acid and growth hormone secretion studies in rats and dogs.

Rigamonti AE, Müller EE.

Alcohol. 2000 Apr;20(3):293-304.

PMID:
10869872
20.

Potent long-acting growth hormone releasing factor analogues.

Rivier J, Rivier C, Galyean R, Yammamoto G, Vale W.

Ann N Y Acad Sci. 1988;527:44-50.

PMID:
3133968
Items per page

Supplemental Content

Write to the Help Desk